Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer
Zubritsky, Lindsey, Leitzel, Kim, Ali, Suhail M., Köstler, Wolfgang, Fuchs, Eva-Maria, Costa, Luis, Knight, Robert D., Laadem, Abderrahmane, Sherman, Matthew L., Lipton, Allan
Published in Journal of clinical oncology (20.10.2012)
Published in Journal of clinical oncology (20.10.2012)
Get full text
Journal Article
Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer
Lipton, Allan, Zubritsky, Lindsey, Leitzel, Kim, Ali, Suhail M., Koestler, Wolfgang, Fuchs, Eva-Maria, Costa, Luis, Knight, Robert D., Laadem, Abderrahmane, Sherman, Matthew L.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Elevated serum activin A and survival in CRPC
Ali, Suhail M., Zubritsky, Lindsey, Jacobus, Susanna J., Leitzel, Kim, Regan, Meredith M., Nakabayashi, Mari, Knight, Robert D., Laadem, Abderrahmane, Sherman, Matthew L., Lipton, Allan, Kantoff, Philip
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Abstract 391: Serum ferritin predicts response to trastuzumab and is a biomarker for breast and pancreatic cancers: A potential novel inflammatory effector mechanism
Alkhateeb, Ahmed A., Zubritsky, Lindsey, Leitzel, Kim, Ali, Suhail M., Campbell-Baird, Cynthia, Koestler, Wolfgang, Fuchs, Eva-Marie, Lipton, Allan, Connor, James
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article